🇺🇸 Bupivicaine in United States

189 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pain — 42 reports (22.22%)
  2. Drug Ineffective — 29 reports (15.34%)
  3. Drug Withdrawal Syndrome — 19 reports (10.05%)
  4. Nausea — 19 reports (10.05%)
  5. Drug Interaction — 16 reports (8.47%)
  6. Hypoaesthesia — 15 reports (7.94%)
  7. Off Label Use — 13 reports (6.88%)
  8. Overdose — 13 reports (6.88%)
  9. Lagophthalmos — 12 reports (6.35%)
  10. Vomiting — 11 reports (5.82%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Bupivicaine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Bupivicaine in United States?

University of Colorado, Denver is the originator. The local marketing authorisation holder may differ — check the official source linked above.